PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
IPO Year:
Exchange: NASDAQ
Website: 1800petmeds.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/25/2023 | $20.00 | Buy | Lake Street |
| 1/25/2022 | $25.00 → $21.00 | Underweight | Morgan Stanley |
| 1/20/2022 | $32.00 | Neutral → Buy | Sidoti |
| 11/18/2021 | $25.00 | Underweight | Morgan Stanley |
| 10/1/2021 | $28.00 | Hold | Jefferies |
| 8/5/2021 | $22.00 | Underperform | Credit Suisse |
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
DELRAY BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Wednesday, November 6, 2024 at 4:30pm Eastern Time to discuss its financial results for the fiscal second quarter ended September 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Wednesday, November 6, 2024Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8
DELRAY BEACH, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), today announced that on September 27, 2024, PetMeds granted two equity awards previously approved by its Board of Directors to two newly hired executives as a material inducement to employment. PetMeds granted Doug Krulik, Chief Accounting Officer, 40,000 time-based restricted stock units ("RSUs") and granted Robyn D'Elia, Chief Financial Officer, 250,000 time-based RSUs. The RSUs will vest over three years in equal one-third increments on each of the first three (3) anniversaries of the grant date, subject to continued employment with the Company on eac
DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot
DELRAY BEACH, Fla., Aug. 21, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference, to be held September 4-6, 2024 in New York. Sandra Campos, CEO and President, will hold a fireside chat on September 6, 2024 at 7:45 a.m. (Eastern Time). A live audio webcast of the fireside chat will be available on the "Events & Presentations" section of PetMed's investor relations website at https://investors.petmeds.com. After the event, a replay of the fireside chat will be archived and available on this same website for approximately 90 days. About PetMed Express, Inc.
DELRAY BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its first quarter ended June 30, 2024. Quarterly Highlights for Q1, Fiscal 2025 Net sales were $68 million, (13)% lower than the prior year comparable quarter.Net income was $3.8 million, or $0.18 diluted earnings per share. This compares to net loss of $(1.1) million, or $(0.06) diluted earnings per share, for the prior year comparable quarter.Increase in net income is primarily attributed to a $8.7 million reversal of accumulated stock compensation expense associated with departure of the former CEO, partially off
DELRAY BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Doug Krulik as Chief Accounting Officer (CAO) effective August 19, 2024. Krulik comes to PetMeds with more than 20 years of leadership experience in finance and accounting, most recently with Etherio Holdings as its Vice President Finance and Controller. In this newly created role, he will oversee all aspects of the Company's accounting functions, including financial reporting, treasury, tax, compliance, and internal controls. Krulik will report directly to the Office of the Chief Financial Officer. "Doug'
DELRAY BEACH, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, August 6, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal first quarter ended June 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, August 6, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 844-826-3035International number: 412-317-5195Webcast: 1Q Ear
DELRAY BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2024. Quarterly Highlights Net sales for the quarter ended March 31, 2024, were $66.5 million, compared to $62.4 million for the fourth quarter in the prior year, an increase of 6.6%, driven by the acquisition of PetCareRx partially offset by a decline in PetMeds legacy sales.Net loss for the quarter ended March 31, 2024 was $(5.0) million, or $(0.25) diluted earnings per share. This compares to net loss of $(0.2) million, or $(0.01) diluted earnings per share, for
Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology Officer Company Announces CFO transition DELRAY BEACH, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced several changes to its executive leadership team to further advance key initiatives to improve the customer experience, and to accelerate growth and profitability. Chief Operating Officer Caroline Conegliano joins PetMeds as Chief Operating Officer (COO), in a newly created role and expansion of the executive leadership team. Ms. Conegliano brings nearly two decades of experi
DELRAY BEACH, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Carla Dodds as Chief Marketing Officer (CMO). She brings extensive experience in leadership roles encompassing marketing, strategy and operations for major global companies including Walmart, MasterCard, Curacao, Omnilife-Chivas Group, and Penske Media Corporation. As CMO, Dodds will be responsible for leading PetMeds' integrated marketing strategy including brand and content, digital and lifecycle marketing, co-op media, customer acquisition and retention, customer insights and market research, social media
8-K - PETMED EXPRESS INC (0001040130) (Filer)
S-8 - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
S-8 - PETMED EXPRESS INC (0001040130) (Filer)
10-Q - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
DEFA14A - PETMED EXPRESS INC (0001040130) (Filer)
DEFA14A - PETMED EXPRESS INC (0001040130) (Filer)
DELRAY BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Wednesday, November 6, 2024 at 4:30pm Eastern Time to discuss its financial results for the fiscal second quarter ended September 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Wednesday, November 6, 2024Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8
DELRAY BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its first quarter ended June 30, 2024. Quarterly Highlights for Q1, Fiscal 2025 Net sales were $68 million, (13)% lower than the prior year comparable quarter.Net income was $3.8 million, or $0.18 diluted earnings per share. This compares to net loss of $(1.1) million, or $(0.06) diluted earnings per share, for the prior year comparable quarter.Increase in net income is primarily attributed to a $8.7 million reversal of accumulated stock compensation expense associated with departure of the former CEO, partially off
DELRAY BEACH, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, August 6, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal first quarter ended June 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, August 6, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 844-826-3035International number: 412-317-5195Webcast: 1Q Ear
DELRAY BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2024. Quarterly Highlights Net sales for the quarter ended March 31, 2024, were $66.5 million, compared to $62.4 million for the fourth quarter in the prior year, an increase of 6.6%, driven by the acquisition of PetCareRx partially offset by a decline in PetMeds legacy sales.Net loss for the quarter ended March 31, 2024 was $(5.0) million, or $(0.25) diluted earnings per share. This compares to net loss of $(0.2) million, or $(0.01) diluted earnings per share, for
DELRAY BEACH, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) ("PetMeds"), will hold a conference call on Tuesday, June 11, 2024 at 4:30pm Eastern time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 11, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0789International number: 2
Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results.AutoShip & Save and PetPlus Membership, 52% of total revenue, up from 42% at the same time last year.Strong balance sheet with $49.4 million of cashThe Company is now current in all of its SEC filings DELRAY BEACH, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS)("PetMeds" or "Company"), Your Trusted Pet Health ExpertTM, today announced its financial results for its third quarter of fiscal year 2024, restated financial statements for the years ended March 31, 2023, 2022 and 2021, and interim financial statements for previously reported quarterly periods in
DELRAY BEACH, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) ("PetMeds" or the "Company"), Your Trusted Pet Health ExpertTM, today announced its selected preliminary financial results for its third quarter ended December 31, 2023. These preliminary financial results are unaudited, based on currently available information and do not present all necessary information for a complete understanding of the Company's financial condition as of December 31, 2023 or its results of operations for the quarter ended December 31, 2023. Quarterly Highlights Net sales for the quarter ended December 31, 2023, are expected to be $65.3 million, compared to $58.9 million for the
DELRAY BEACH, Fla., Jan. 29, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) (the "Company"), Your Trusted Pet Health ExpertTM will hold a conference call on Thursday, February 8, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal third quarter ended December 31, 2023. Financial results will be issued in a press release prior to the call. PetMeds' management will host the conference call, followed by a question and answer period. Date: Thursday, February 8, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0789 International number: 201-689-8562Webcast: 3Q Webcast Link Please call the conference telephone number 5-10 mi
DELRAY BEACH, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) (the "Company"), Your Trusted Pet Health ExpertTM will hold a conference call on Monday, October 30, 2023 at 4:30pm Eastern time to discuss its financial results for the fiscal second quarter ended September 30, 2023. Financial results will be issued in a press release prior to the call. PetMeds' management will host the conference call, followed by a question and answer period. Date: Monday, October 30, 2023Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0791 International number: 201-689-8563Webcast: 2Q Webcast Link Please call the conference telephone number 5-10 m
DELRAY BEACH, Fla., July 31, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) ("PetMeds" or "Company"), Your Trusted Pet Health Expert™, today announced its financial results for its first quarter ended June 30, 2023. Quarterly Highlights Net sales for the quarter ended June 30, 2023, were $78.2 million, compared to $70.2 million for the first quarter in the prior year, an increase of 11.5%. PetMeds reported an increase in new customers of 25% year over year for the quarter ended June 30, 2023, representing the third consecutive quarter of new customer growth. This includes new customers from the PetCareRx acquisition.Net loss for the quarter ended June 30, 2023 was $(0.9) mi
4 - PETMED EXPRESS INC (0001040130) (Issuer)
3 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
3 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
Investor Ryan Cohen founded Chewy Inc (NYSE:CHWY) back in 2011 as a play on the growing trend of pet supplies and pet health products. New data suggests Cohen may have been early to the trend, with spending on pet supplies and pet insurance seeing a large increase. What Happened: Serving as CEO of Chewy from 2011 to 2018, Cohen put an emphasis on the wide variety of pet products offered to consumers online and providing strong customer service. Cohen sold Chewy to PetSmart in 2017 for $3.35 billion in the largest e-commerce acquisition at the time. The investor may have been early to seeing trends in the pet sector, as a recent Similarweb report shows the pet supply category growing
Cat-themed cryptocurrencies surged Thursday after controversial trader "Roaring Kitty" returned to social media with an intriguing post. What Happened: Keith Gill, better known online as “Roaring Kitty,” posted a photo of a cartoonish dog, marking his first post since June 18. The photo shows a dog looking sideways, sticking its tongue out, without any captions. pic.twitter.com/jQBMX4jwjR— Roaring Kitty (@TheRoaringKitty) June 27, 2024 As has been the case over the last month-and-a-half, cryptocurrencies with "Kitty" in their names began to surge. Within minutes of the post, Solana (CRYPTO: SOL)-based Kitty AI spiked 34% to its weekly highs. While profit-taking halted the asc
Several pet-related stocks experienced significant upward movement on Thursday after Keith Gill, known as Roaring Kitty, posted a cartoon image of a dog on X, formerly known as Twitter. What’s Happening: Gill’s tweet featured a simple cartoon image of a dog, yet it was enough to send shares of several companies soaring. Among the notable movers were Chewy, Inc. (NYSE:CHWY), which saw its stock jump by around 10%, PetMed Express, Inc. (NASDAQ:PETS) around 4% and Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), also up 4%. What Else: Keith Gill, under the pseudonym Roaring Kitty, gained fame for his early and bullish stance on GameStop, which he shared on platforms like Reddit and
https://x.com/TheRoaringKitty/status/1806371920495186041
Lake Street analyst Ryan Meyers maintains PetMed Express (NASDAQ:PETS) with a Buy and lowers the price target from $9 to $7.
Shares of Streamline Health Solutions, Inc. (NASDAQ:STRM) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter EPS results. Streamline Health reported quarterly losses of 5 cents per share which missed the analyst consensus estimate of 4 cents per share. The company reported quarterly sales of $4.33 million which beat the analyst consensus estimate of $4.31 million, according to data from Benzinga Pro. Streamline Health Solutions shares dipped 23.3% to $0.4902 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers DDC Enterprise Limited (NYSE:DDC) surged 101% to $1.04. DDC Enterprise said it has acqu
Gainers Golden Heaven Group Hldgs (NASDAQ:GDHG) shares moved upwards by 74.8% to $0.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $16.1 million. Neo-Concept International (NASDAQ:NCI) shares moved upwards by 15.07% to $0.73. The company's market cap stands at $14.7 million. Singing Machine Co (NASDAQ:MICS) shares moved upwards by 11.7% to $2.1. The market value of their outstanding shares is at $13.4 million. Wah Fu Education Group (NASDAQ:WAFU) shares moved upwards by 9.99% to $2.09. The company's market cap stands at $9.2 million. Digital Brands Group (NASDAQ:DBGI) shares rose 9.82% to $1.9. The company's market cap stands at $3.7 million
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $6.5 to $3.5.
Shares of Oracle Corporation (NYSE:ORCL) rose sharply in today's pre-market trading after the company reported fourth-quarter financial results. Oracle posted weaker-than-expected earnings for its fiscal fourth quarter. The company also announced a partnership with Alphabet Inc’s (NASDAQ:GOOGL) (NASDAQ:GOOG) Google Cloud. Oracle shares jumped 9% to $135.00 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers Golden Heaven Group Holdings Ltd (NASDAQ:GDHG) rose 70.3% to $0.3049 in today's pre-market trading. WANG & LEE GROUP, Inc. (NASDAQ:WLGS) shares rose 43.1% to $0.8760 in pre-market trading after surging 16% on Tuesday. S
DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot
DELRAY BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Doug Krulik as Chief Accounting Officer (CAO) effective August 19, 2024. Krulik comes to PetMeds with more than 20 years of leadership experience in finance and accounting, most recently with Etherio Holdings as its Vice President Finance and Controller. In this newly created role, he will oversee all aspects of the Company's accounting functions, including financial reporting, treasury, tax, compliance, and internal controls. Krulik will report directly to the Office of the Chief Financial Officer. "Doug'
Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology Officer Company Announces CFO transition DELRAY BEACH, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced several changes to its executive leadership team to further advance key initiatives to improve the customer experience, and to accelerate growth and profitability. Chief Operating Officer Caroline Conegliano joins PetMeds as Chief Operating Officer (COO), in a newly created role and expansion of the executive leadership team. Ms. Conegliano brings nearly two decades of experi
DELRAY BEACH, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Carla Dodds as Chief Marketing Officer (CMO). She brings extensive experience in leadership roles encompassing marketing, strategy and operations for major global companies including Walmart, MasterCard, Curacao, Omnilife-Chivas Group, and Penske Media Corporation. As CMO, Dodds will be responsible for leading PetMeds' integrated marketing strategy including brand and content, digital and lifecycle marketing, co-op media, customer acquisition and retention, customer insights and market research, social media
DELRAY BEACH, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Justin Mennen to the Company's Board of Directors ("the Board"), effective June 3, 2024. Mennen brings over 25 years of technology experience to the Company, including senior leadership roles at Rite Aid, CompuCom, Estée Lauder Companies and Dell Technologies. "Justin's vision and experience will be invaluable in advancing our digital initiatives and we are thrilled to have him join the Board," said Leslie C. G. Campbell, Chairman of the Board. "He has a strong track record of technology leadership ac
DELRAY BEACH, Fla., Jan. 8, 2024 /PRNewswire/ -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS), Your Trusted Pet Health Expert™, announces the appointment of Leslie C. G. Campbell as Chairman of the Board effective January 5, 2024, as part of the company's ongoing Board composition and succession planning. Ms. Campbell has served on PetMeds' Board since 2018 and will continue to serve as Chair of the Compensation Committee and a member of the Audit and Corporate Governance and Nominating Committees. Ms. Campbell previously served as Chair of the Corporate Governance and Nomi
DELRAY BEACH, Fla., May 18, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS), Your Trusted Pet Health Expert™, announced the appointment of Sandra Y. Campos to its Board of Directors effective May 17, 2023. "We are delighted to welcome Ms. Campos to PetMeds' board of directors," said Dr. Gian Fulgoni, Board Chairman. "Sandra's vast experience with brand management, digital transformations, and supply chain management, will undoubtedly help the Company as we continue to deliver "Nose-to-Tail" services to our pet families and continue to define the PetMeds' brand as "Your Trusted Pet Health Expert." Ms. Campos serves on the Boards of Big Lots, a nationwide retailer
Seasoned executive brings a wealth of financial leadership to further accelerate the company's digital transformation. DELRAY BEACH, Fla., July 22, 2022 /PRNewswire-PRWeb/ -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health Expert®, announces the appointment of Christine Chambers as its Chief Financial Officer, effective on August 3. Chambers is an experienced finance professional with extensive knowledge in the digital consumer space, most recently serving as Senior Vice President, CFO and Treasurer of Seattle-based RealNetworks. Prior to that, she was Vice President, Finance at Rosetta Stone. Chambers also has served as Deputy Director, Budget and Planning at the Bill & Melinda
DELRAY BEACH, Fla., July 18, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health Expert, announces the appointment of Christine Chambers as its Chief Financial Officer, effective on August 3, 2022. Chambers is an experienced finance professional with extensive knowledge in the digital consumer space, most recently serving as Senior Vice President, CFO and Treasurer of Seattle-based RealNetworks. Prior to that, she was Vice President of Finance at Rosetta Stone. Chambers also has served as Deputy Director, Budget and Planning at the Bill & Melinda Gates Foundation. She earned an MBA from the University of Washington and a bachelor's degree in finance fr
Raj Batra, President of Siemens' Digital Industries US, Brings 20+ Years of Industrial Experience Leslie C. G. Campbell to Assume Role as Chair of the Board Shapeways, Inc. (NYSE:SHPW) ("Shapeways") a leader in the large and fast-growing digital manufacturing industry, announced today that Raj Batra has been appointed to the Company's Board of Directors ("Board") as an independent director, subject to the receipt of all applicable regulatory approvals. With 20+ years of experience in industrial automation and digitalization, Mr. Batra currently serves as President of Digital Industries (DI) for Siemens USA, where he guides the DI strategy and engagement and oversees all sales, marketing,
Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00
Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously
Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00
Morgan Stanley initiated coverage of PetMed Express with a rating of Underweight and set a new price target of $25.00
Jefferies initiated coverage of PetMed Express with a rating of Hold and set a new price target of $28.00
Credit Suisse resumed coverage of PetMed Express with a rating of Underperform and set a new price target of $22.00
Sidoti downgraded PetMed Express from Buy to Neutral and set a new price target of $39.00
Sidoti upgraded PetMed Express from Neutral to Buy
Sidoti upgraded PetMed Express from Neutral to Buy
Sidoti downgraded PetMed Express from Buy to Neutral